Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market
Read More 2 minute read Pharma Industry News Indian CDMO Gland Pharma to acquire French CDMO Cenexi Gland Pharma, an Indian contract development and manufacturing organization (CDMO), through its Singapore subsidiary Gland Pharma International, has… byRaghuram KadariNovember 30, 2022